Combination anti-HIV antibodies provide sustained virological suppression
Michael C. Sneller(National Institutes of Health), Jana Blažková(National Institutes of Health), J. Shawn Justement(National Institutes of Health), Victoria Shi(National Institutes of Health), Brooke D. Kennedy(National Institutes of Health), Kathleen Gittens(National Institutes of Health Clinical Center), Jekaterina Tolstenko(National Institutes of Health), Genevieve McCormack(National Institutes of Health), Emily J. Whitehead(National Institutes of Health), Rachel F. Schneck(National Institutes of Health), Michael A. Proschan(National Institutes of Health), Erika Benko(Maple Leaf Medical Clinic), Colin Kovacs(Maple Leaf Medical Clinic), Cihan Oguz(Frederick National Laboratory for Cancer Research), Michael S. Seaman(Beth Israel Deaconess Medical Center), Marina Caskey(Rockefeller University), Michel C. Nussenzweig(Howard Hughes Medical Institute), Anthony S. Fauci(National Institutes of Health), Susan Moir(National Institutes of Health), Tae‐Wook Chun(National Institutes of Health)
Cited by 171Open Access